Result
€179,101 ▲ 146%
The result rose in 2025 from €72,728 to €179,101.
LVX Medica
Lifetime
2 annual accounts with figures on one time axispeak €260,619 (2025)
€260,619▲ 145%
peak €179,101 (2025)
€179,101▲ 146%
peak €254,829 (2025)
€254,829▲ 237%
€28,830▲ 284%
Board1 name since 2023
1 director
Documentsfilings and deeds
24-04-20266 days before the deadline
2025micro format
Gross margin from €106,268 to €260,619Result from €72,728 to €179,101Equity from €75,728 to €254,829Debts from €7,509 to €28,830Cash from €55,847 to €151,027
Key points
from the 2025 annual accountsChecked score
Bankruptcy probability within 12 months
Financial strength
Score breakdown
Comparable companies, two years later
In July 2024, 39,274 companies had the same profile as LVX Medica has now. Each dot stands for 99 companies, two years later.
95.8%
were still trading
2.3%
stopped another way
1.8%
went bankrupt
Another 0.1% stopped without a precise date, possibly only after those two years.
Test of the method
The method was tested on the 497,331 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.
| Group | Expected | Actual |
|---|---|---|
| 1 | 0.2% | 0.2% |
| 2 | 0.3% | 0.5% |
| 3 | 0.5% | 0.6% |
| 4 | 0.7% | 0.8% |
| 5 | 0.9% | 0.9% |
| 6 | 1.3% | 1.5% |
| 7 | 1.6% | 1.8% |
| 8 | 1.8% | 1.8% |
| 9 | 2.9% | 3.1% |
| 10 | 5.6% | 6.1% |
A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.
This is an observation about 39,274 companies, not a prediction for LVX Medica. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.
Credit verdict
Credit check for an amount and term of your choice
Show the recommended maximum and see how the verdict changes with amount, term and advance.
The scores and ratios are Checked's own calculations, not a credit decision.
Signals
Recent changes
Registered in the Peppol Directory
Reachable for e-invoices through 0208:0805627263
First establishment
Chaussée de Beaumont 76, Froidchapelle
Incorporation
Founding capital of €3,000, 120 shares · Founder: · Appointment: (director) · published on 12-09-2023 · Gazette deed
Official details
Source: KBO- Status
- Active since 08-09-2023Normal situation
- Activity
- “En assurant la gestion d'un centre médical ou d'un cabinet médical,en ce compris l'acquisition,la…” (deed in French)From the articles, 2 activitiesNo NACE code in the KBO yet
- Establishment unit
- 2.350.168.4586440 Froidchapelle, since 01-10-2023
- Financial year end
- 30 September
- Peppol
- Reachable since 16-12-2025
Annual accounts to 30-09-2025
- €283,659▲ 241%
- Filing
- Filed on 24-04-2026, 6 days before the end of the filing period
Insights on LVX Medica
LVX Medica has been active since 2023 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €254,829 and a net result of €179,101.
Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.
Key facts about LVX Medica
- What is the company number of LVX Medica?
- The company number of LVX Medica is 0805.627.263. The VAT number is the same number with BE in front: BE 0805.627.263.
- Where is LVX Medica based?
- The registered office is at Chaussée de Beaumont 76, 6440 Froidchapelle.Company details
- What is the legal form of LVX Medica?
- LVX Medica is a private limited company (BV).
- When was LVX Medica founded?
- LVX Medica was founded on 08-09-2023.
- Is LVX Medica still active?
- Yes, LVX Medica is an active enterprise in the KBO register.
- What is the turnover of LVX Medica?
- The turnover in financial year 2025 is ≈ €520,000. This figure is estimated from the gross margin of €260,619 and 877 comparable companies of the same size. It probably lies between €360,000 and €760,000. It is a rough estimate.Financials
- Is LVX Medica profitable?
- In financial year 2025, LVX Medica made a profit of €179,101.
- Where can I find the annual accounts of LVX Medica?
- LVX Medica filed 2 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
- When are the next annual accounts of LVX Medica due?
- LVX Medica must file the annual accounts for financial year 2026 by 30-04-2027.Timeline
Next steps
Work out how much credit to give this customer and on what payment terms.Credit check Check what to know before you do business with this company.Supplier due diligence Check whether you can accept this company as a client under the anti-money-laundering law.AML client file Check which of your other customers you can e-invoice via Peppol.Peppol check Compare this company with its sector.Sector benchmark See what changed in the latest annual accounts.What changed
See how customers, suppliers and banks see your own company and what to improve first.